MedPath

Peking University Third Hospital (Peking University Third Clinical Medical College)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Visual Outcomes and Patient Satisfactory After PanOptix Implantation in Hyperopic Cataract Patients

Not yet recruiting
Conditions
Hyperopia
Cataract
First Posted Date
2023-02-08
Last Posted Date
2023-02-08
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
44
Registration Number
NCT05716269

Clinical Evaluation of Enteral-extended Anti-reflux Stents for Pancreatic Pseudocyst

Phase 2
Recruiting
Conditions
Pancreatic Pseudocyst
Interventions
Combination Product: Plant enteral-extended anti-reflux stents
Combination Product: Plant traditional stents
First Posted Date
2023-02-08
Last Posted Date
2023-02-08
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
52
Registration Number
NCT05716594
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Safety and Tolerability of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Early Phase 1
Recruiting
Conditions
Bietti's Crystalline Dystrophy
Interventions
Drug: ZVS101e
First Posted Date
2023-02-06
Last Posted Date
2023-02-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
6
Registration Number
NCT05714904
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Comparison of MBR + Suture Tape and Anatomic Reconstruction for CLAI in GJL Cases: A Prospective Cohort Study

Recruiting
Conditions
Hypermobility Syndrome
Ankle Sprains
Interventions
Procedure: Modified Broström + Suture tape augmentation operation
Procedure: Anatomic reconstruction operation
First Posted Date
2023-01-26
Last Posted Date
2023-01-26
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
86
Registration Number
NCT05698446
Locations
🇨🇳

Peking University Third Hospital, Beijing, China

A Study on the Status Quo of Physical Exercise for the Elderly

Active, not recruiting
Conditions
Community
Physical Exercise
Elderly
First Posted Date
2023-01-26
Last Posted Date
2023-01-26
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
250
Registration Number
NCT05698472
Locations
🇨🇳

Peking University Third Hospital, Peking, Beijing, China

Tetrandrine Tablets Used in Hospitalized Adults With COVID-19

Phase 4
Withdrawn
Conditions
COVID-19
Interventions
Drug: Tetrandrine
First Posted Date
2023-01-25
Last Posted Date
2024-10-01
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
414
Registration Number
NCT05697029
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Prediction of Pulmonary Rehabilitation Outcomes in Patients With Chronic Respiratory Disease Based on Metabolomics: a Prospective Cohort Study

Not yet recruiting
Conditions
Chronic Obstructive Pulmonary Disease
Bronchiectasis
Interventions
Other: metabonomics
First Posted Date
2023-01-12
Last Posted Date
2023-04-18
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
300
Registration Number
NCT05681364

Oral Vitamin D2 for Prevention of COVID-19

Not Applicable
Recruiting
Conditions
Healthy Volunteers
Interventions
Other: placebo
Drug: Vitamin D2
First Posted Date
2023-01-06
Last Posted Date
2023-01-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
218
Registration Number
NCT05673980
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Efficacy and Safety of Minodronate in Patients With Low Back Pain

Phase 4
Not yet recruiting
Conditions
Postmenopausal Osteoporosis
Interventions
Drug: Minodronate
Drug: Alendronate
First Posted Date
2022-12-09
Last Posted Date
2022-12-09
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
72
Registration Number
NCT05645289
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Phase 2
Recruiting
Conditions
Proliferative Diabetic Retinopathy
Interventions
Drug: proactive Anti-VEGF (conbercept) use
Drug: passive Anti-VEGF (conbercept) use
First Posted Date
2022-12-08
Last Posted Date
2022-12-14
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
80
Registration Number
NCT05642793
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy